Categories:
COPD, OCS (Articles)
Overuse of short-acting beta-agonist bronchodilators in COPD during periods of clinical stability
INHALE prepares regular PO and Clinical level newsletters that contain:
Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs.
Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.